Vascular endothelial growth factor of the lung: friend or foe

被引:53
|
作者
Tuder, Rubin M. [1 ]
Yun, Jeong H. [1 ]
机构
[1] Univ Colorado, Sch Med, Program Translat Lung Res, Div Pulm & Crit Care Med,Dept Med, Denver, CO 80262 USA
关键词
D O I
10.1016/j.coph.2008.03.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The discovery of vascular endothelial growth factor (VEGF) changed the field of angiogenesis. We have learned that VEGF has broader actions than merely a driver of tumor angiogenesis, particularly that VEGF controlled several fundamental functions and properties of endothelial cells and nonendothelial cells. The lung is one of the main organs where VEGF controls several crucial physiological functions. These actions rely on tightly regulated temporal and concentration gradients of VEGF and VEGF receptor expression in the lung. Excessive or diminished VEGF have been linked to abnormal lung phenotypes and, in humans, linked to several diseases. The beneficial and detrimental actions of VEGF underscore that therapeutic targeting of VEGF in disease has to carefully consider the lung biology of VEGF.
引用
收藏
页码:255 / 260
页数:6
相关论文
共 50 条
  • [1] Clinical implications for Vascular Endothelial Growth Factor in the lung: friend or foe?
    Andriana I Papaioannou
    Konstantinos Kostikas
    Panagoula Kollia
    Konstantinos I Gourgoulianis
    Respiratory Research, 7
  • [2] Clinical implications for Vascular Endothelial Growth Factor in the lung: friend or foe?
    Papaioannou, Andriana I.
    Kostikas, Konstantinos
    Kollia, Panagoula
    Gourgoulianis, Konstantinos I.
    RESPIRATORY RESEARCH, 2006, 7 (1)
  • [3] Vascular endothelial growth factor in the lung
    Voelkel, NF
    Vandivier, RW
    Tuder, RM
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2006, 290 (02) : L209 - L221
  • [4] Connective tissue growth factor - Friend or foe?
    Oemar, BS
    Luscher, TF
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (08) : 1483 - 1489
  • [5] Fibroblast growth factor 23: friend or foe in uremia?
    Moe, Orson W.
    JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (07): : 2354 - 2356
  • [6] THE VASCULAR ENDOTHELIUM - FRIEND OR FOE
    VERRIER, ED
    ANNALS OF THORACIC SURGERY, 1993, 55 (04): : 818 - 819
  • [7] Role of vascular endothelial growth factor receptor 1 and vascular endothelial growth factor receptor 2 in the vasodilator response to vascular endothelial growth factor in the neonatal piglet lung
    Janvier, A
    Nadeau, S
    Baribeau, J
    Perreault, T
    CRITICAL CARE MEDICINE, 2005, 33 (04) : 860 - 866
  • [8] Targeting Vascular Endothelial Growth Factor in Lung Cancer
    Hasani, Arman
    Leighl, Natasha B.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S484 - S486
  • [9] Vascular endothelial growth factor in human preterm lung
    Lassus, P
    Ristimäki, A
    Ylikorkala, O
    Viinikka, L
    Andersson, S
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (05) : 1429 - 1433
  • [10] Nanoparticles and the lung: friend or foe?
    Prakash, Y. S.
    Matalon, Sadis
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2014, 306 (05) : L393 - L396